вторник, 27 сентября 2011 г.

BioSante Pharmaceuticals Comments On Boehringer Ingelheim Clinical Test Results In Treatment Of Female Sexual Dysfunction

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need. Boehringer today, at the European Society for Sexual Medicine annual meeting in Lyon, France, reported clinical test results of flibanserin, a drug candidate which treats HSDD by blocking the brain's release of serotonin, a chemical that regulates mood, appetite, sleep and memory and, in time, triggers the production of dopamine, a chemical associated with the stimulation of desire.


BioSante's product for this market is LibiGel, a transdermal testosterone gel targeting menopausal women. LibiGel currently is in late-stage Phase III clinical studies for the treatment of HSDD. BioSante President and CEO Stephen M. Simes, said, "The fact that one of the largest pharmaceutical companies in the world is targeting this condition is important and exciting medical news. For ten years, men have enjoyed the option of using drugs to treat erectile dysfunction but there is no pharmaceutical product approved by the FDA for the treatment of HSDD. BioSante is committed to bringing women an option in their decision-making about their own sexuality."


Boehringer has been studying flibanserin in pre-menopausal women. Data, pooled from three Phase III studies, presented today from trials in Europe and the U.S., show a statistically significant improvement in satisfying sexual events (SSEs) compared to placebo, with an average difference of 0.70 SSEs per four week period. The results reported by Boehringer for flibanserin are similar to data reported by Proctor & Gamble for their Intrinsa testosterone patch (now owned by Warner Chilcott).


As previously announced by BioSante, treatment with LibiGel in a Phase II double-blind, placebo-controlled, clinical trial, conducted in the U.S., in surgically menopausal women distressed by their low sexual desire and activity, significantly increased satisfying sexual events in surgically menopausal women suffering from FSD. The Phase II trial results showed LibiGel significantly increased the number of satisfying sexual events by 238 percent versus baseline (p

вторник, 20 сентября 2011 г.

Halt Medical Receives Canadian License For Fibroid Treatment Device

Halt Medical, Inc. announced that it has been approved to market the Tulip™ Radiofrequency Volumetric Thermal Ablation (RFVTA) probe in Canada. "The license we just received from Health Canada brings us an important step closer to our goal of making our uterine sparing procedure available to the millions of women in North America who suffer with uterine fibroids", said Russ DeLonzor, President and COO of Halt Medical. "The approvals we've now received from Canada and the European Union for general use and for treating uterine fibroids, plus our recent clearance by the FDA to market our products for general surgical use (not specifically indicated for fibroids) in the United States has us well positioned to bring our solutions to most of the major global markets in the near future", said DeLonzor.


Source: Halt Medical, Inc

вторник, 13 сентября 2011 г.

Heart Disease Deaths Continue To Decline In American Women

Heart disease deaths in American women continued to decline in 2005, and for the first time, have declined six years consecutively, covering the years 2000-2005, according to newly analyzed data announced today by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.


NHLBI experts analyzed preliminary data for 2005, the most recent year for which data are available. The analysis shows that women are living longer and healthier lives, and dying of heart disease at much later ages than in the past years.


In New York City today, The Heart Truth - NHLBI's landmark heart health awareness campaign for women - rolls out the red carpet for its Red Dress Collection 2008 Fashion Show - presented by Diet Coke, with national sponsors Johnson & Johnson, Swarovski, and partner Bobbi Brown Cosmetics - at Mercedes-Benz Fashion Week. More than 20 celebrated women will unite with America's top designers on the runway to showcase the annual collection of one-of-a-kind Red Dresses and raise awareness of heart disease in women.


"Nothing draws attention like a little red dress, so this is the Heart Truth's symbol," said First Lady Laura Bush, official national ambassador of the Heart Truth campaign. "Across the country, people are rallying around that dress. Women are taking heart disease more seriously. So are their doctors. And every year from 2000 to 2005, heart disease deaths among women decreased. "


"This is good progress," Mrs. Bush added. "But we still want more people to know the Heart Truth. Too many women, especially African American women, die of heart disease. More than 80 percent of middle-aged women have at least one risk factor and many of them don't know it."
"Considerable progress continues to be made in the fight against heart disease in women," said Elizabeth G. Nabel, M.D., director of NHLBI.


But serious challenges remain - one in four women dies from heart disease. Women of color have higher rates of some risk factors for heart disease and are more likely to die of the disease.


"Unfortunately, many women still do not take heart disease seriously and personally," said Dr. Nabel. "Millions of women still have one or more risk factors for heart disease, dramatically increasing their risk of developing heart disease. In fact, having just one risk factor increases a woman's chance of developing heart disease twofold."


"I am just delighted that for the sixth year on National Wear Red Day, the fashion and entertainment industries will join forces on behalf of The Heart Truth to share an urgent message to American women about heart health," said Dr. Nabel. "Although we've helped to dramatically increase awareness among women that heart disease is their leading cause of death, our mission remains to educate women about the seriousness of heart disease and inspire them to take action to reduce their risk."


The Heart Truth effort aims to spread the word that heart disease is largely preventable. In fact, just by leading a healthy lifestyle - such as following a heart healthy eating plan, getting regular physical activity, maintaining a healthy weight, and not smoking - Americans can lower their risk by as much as 82 percent. Risk factors for heart disease include:















- age (55 or older for women);

- a family history of early heart disease;

- high blood pressure;

- high blood cholesterol;

- diabetes;

- smoking;

- being overweight or obese; and

- being physically inactive.


NHLBI's introduction of The Heart Truth's Red Dress as the national symbol for women and heart disease awareness in 2002 sparked a national movement that has united partners to promote the common goal of a greater awareness of heart disease and better heart health for all women. The Red Dress is fast becoming one of the most recognizable health symbols in the United States. About half of women recognize the Red Dress as the national symbol for women and heart disease and about half of women are aware that heart disease is the No. 1 killer of women.


Walking in this year's Fashion Show are Hollywood leading ladies, including Allison Janney, Ana Ortiz, Camryn Manheim, Cheryl Hines, Cicely Tyson, Emma Roberts, Heidi Klum, Jenna Fischer, Joss Stone, Leighton Meester, Lisa Rinna, Maria Menounos, Mary Lynn Rajskub, Molly Sims, Rita Moreno, and Sara Ramirez.


Participating designers in the 2008 Collection include Ali Rahimi, Badgley Mischka, Calvin Klein, Carmen Marc Valvo, Catherine Malandrino, Daniel Swarovski, Donna Karan, Marc Jacobs, Marchesa, Michael Kors, Monique L'Huillier, Oscar de la Renta, Rachel Roy, Ralph Lauren, Tracy Reese, and Zac Posen.


Friday, Feb. 1, 2008, is National Wear Red Day when thousands of Americans across the country will wear red to unite in the national movement to give women a personal and urgent reminder about their risk for heart disease. The day serves as a reminder to every woman to care for her heart, because heart disease is the #1 killer of women.


About The Heart Truth


The Heart Truth is a national awareness campaign for women about heart disease sponsored by NHLBI, part of the National Institutes of Health, U.S. Department of Health and Human Services.
The Heart Truth's Red Dress reminds women of the need to protect their heart health, and inspires them to take action. NHLBI continues to lead the nation in a landmark heart health awareness movement that is being embraced by millions who share the common goal of greater awareness and better heart health for all women.


The Heart Truth partners include: The Office on Women's Health, Department of Health and Human Services; the American Heart Association; WomenHeart: the National Coalition for Women with Heart Disease, and other organizations committed to the health and well-being of women. To learn more about The Heart Truth campaign, visit hearttruth.


Part of the National Institutes of Health, the National Heart, Lung, and Blood Institute plans, conducts, and supports research related to the causes, prevention, diagnosis, and treatment of heart, blood vessel, lung, and blood diseases; and sleep disorders. The Institute also administers national health education campaigns on women and heart disease, healthy weight for children, and other topics. NHLBI press releases and other materials are available online at nhlbi.nih.


The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.

nih

вторник, 6 сентября 2011 г.

Blogs Comment On World Population Day, Health Care Reform, Other Topics

The following summarizes selected women's health-related blog entries.

~ "World Population Day 2009 -- Time To Finally Make Maternal Health a Priority," Sharon Camp, Huffington Post blogs: World Population Day on Saturday "serves as an urgent reminder that ... governments around the world must boost investments in global health," especially maternal health, despite the global economic recession, Camp, president and CEO of the Guttmacher Institute, writes. Efforts "have fallen short" to date as the "financial resources and political will needed to promote maternal health have been lagging," Camp writes. She notes that the nations are "hardly any closer" to achieving the United Nations' Millennium Development Goals of reducing maternal deaths by 75% and achieving universal access to reproductive health services by 2015. A "critical shortcoming" of recent efforts to achieve the MDGs has been the "reluctance of some governments and advocates to accept that better maternal health cannot be achieved without acknowledging, committing and fully funding sexual and reproductive health services," Camp writes. In particular, "this includes contraceptive services to help women time and space pregnancies as well as treatment of septic or incomplete abortions," and "providing safe abortion services consistent with individual country law," according to Camp. However, there is "some good news," she writes, noting that "[n]ew momentum behind worldwide advocacy efforts may yield the resources and political commitment needed to make a difference." Camp concludes, "It is precisely because resources are scarce that they must be used wisely and efficiently in a way that serves both humanitarian and economic development goals. Investing in saving women's lives fits this bill" (Camp, Huffington Post blogs, 7/9).

~ "Proposed Amendments Would Deny Health Care to Women," Lois Uttley, RH Reality Check: In a blog post addressed to "Gentlemen of the Congress," Uttley asks if they have "forgotten about the women" in their lives as they work on crafting health care reform legislation. Uttley writes,"[S]ome of you are wasting valuable time and taxpayer dollars proposing amendments that would deny health care" to several groups of people, including women. She writes that Republican Sens. Mike Enzi (Wyo.), Orrin Hatch (Utah) and Tom Coburn (Okla.) this week submitted amendments to the Senate Health, Education, Labor and Pensions Committee that would ban coverage for abortion services; protect health care providers and insurers from "'discrimination' for refusing to provide health care requested by their patients," including abortion and emergency contraception; allow federally qualified health centers to "not provide abortions and still get government grants"; and require that "[a]ny independent medical board appointed to determine the benefits that would be included in national health reform coverage would have to include 'professional ethicists ... with specialty in rights of the life of the unborn.'" Meanwhile, Democrats "are spending far too much time trying to win over colleagues who are never going to vote for health reform, no matter if you offer them abortion exclusions or new provider 'conscience' laws or other provisions that would hobble health reform," Uttley writes. She continues, "Don't forget that women are among the strongest supporters of moving quickly on health reform this year" because they are "grassroots experts on what is broken in the current health system," such as insurers' labeling of pregnancy as a "pre-existing condition," using "gender rating" in individual policies and excluding contraception coverage. She asks, "So what do women want?" Uttley provides a "list we've been compiling at Raising Women's Voices for the Health Care We Need." Among the priorities, the list stresses that lawmakers should keep "moral values" out of the debate and that health insurance must be affordable, more simple to understand, fair, portable and universal (Uttley, RH Reality Check, 7/9).














~ "Reports on Judge Sotomayor's Record," Kristina Moore, SCOTUSblog: Moore presents a list of "published reports and substantive blog posts" analyzing Supreme Court nominee Sonia Sotomayor's judicial record ahead of her confirmation hearings beginning Monday. The list is organized by subject matter, including general rulings, access to the courts, business, civil rights, criminal, disability, elections, First Amendment, national security and Second Amendment. The links include an analysis of opinion by the Congressional Research Service, as well as blog posts and reports from media outlets and organizations such as the Association of the Bar of the City of New York, CNN, the Ethics and Public Policy Center, the National Law Journal, the New York Times and the Wall Street Journal (Moore, SCOTUSblog, 7/7).

~ "Abstinence-Only Advocates Attempt To Evolve, but Don't Be So Easily Fooled," Yvonne Fulbright, Huffington Post blogs: Fulbright writes that abstinence-only sex education advocates "have been long organizing a comeback" by "rebranding themselves as science-based and holistic." She continues, "Sounds great, until you remember that this group of powerful virginity zealots, religious leaders and legislators are driven by regressive social values." Fulbright writes that, considering the records of certain abstinence-only groups, "we can't expect their take on 'holistic' and 'healthy' to be anything like that of comprehensive sexual education." According to Fulbright, the attempt of abstinence-only groups to rebrand themselves could be "laughable until you realize that attempting to be more mainstream ... may just work" because the "average citizen will have trouble deciphering what makes the comprehensive versus abstinence-centered efforts so different" (Fulbright, Huffington Post blogs, 7/7).

~ "Jill Stanek Doesn't Want To Prevent Abortions," Kathleen Reeves, RH Reality Check: In the blog, Reeves discusses a recent e-mail exchange between Steven Waldman, editor-in-chief of Beliefnet, and antiabortion-rights advocate Jill Stanek. According to Reeves, Waldman proposed "the following hypothetical situation: more premarital sex and fewer abortions. Would pro-lifers accept this trade-off?" Reeves continues that "Stanek wouldn't" because "she thinks that contraception and sex education lead to more unintended pregnancies." Reeves writes, "What both Waldman and I find more interesting is Stanek's unconditional opposition to sex ed, even if she believed that it did help reduce abortions." In addition, "there's something much more immediate and practical in her refusal to consider contraception a 'lesser evil,'" according to Reeves. She adds, "If she did, she would be admitting that she, and all religious fundamentalists, are wrong. She would be ceding ground to safe sex, to free condoms in bars, to Planned Parenthood." According to Reeves, "A significant contingent of pro-lifers have always done their part to ensure that more abortions happen by resisting sex ed, resisting funding for contraception, and by teaching their children (and other people's children) that condoms don't work." She concludes, "We're going to have to look elsewhere to reduce unplanned pregnancies. Jill Stanek is not interested" (Reeves, RH Reality Check, 7/9).


Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.


© 2009 The Advisory Board Company. All rights reserved.